Children and adolescents with diabetes at Tygerberg Hospital – at risk of cardiovascular complications?
Article Sidebar
Main Article Content
Abstract
Background. In South Africa, the prevalence of dyslipidaemia and hypertension (HT) in paediatric diabetes patients is unknown. Objectives. To determine the prevalence of dyslipidaemia and HT in paediatric diabetic patients seen at Tygerberg Hospital (TBH) and establish whether either is associated with body mass index (BMI), glycosylated haemoglobin (HbA1c) or duration of diabetes. Further, to determine whether the prevalence differs between two specified periods.
Methods. A retrospective study of 154 diabetic patients, aged 1 - 19 years, seen at TBH between 2007 and 2017, was undertaken. The following data were recorded: age; sex; duration of disease (time since diagnosis); height; weight; blood pressure; HbA1c; high-density lipoprotein cholesterol (HDL-C); triglycerides (TG); and low-density lipoprotein cholesterol (LDL-C).
Results. More than half of the patients (57.8%; n=89/154; 95% confidence interval (CI) 51.7 - 65.0) had dyslipidaemia, 16.3% (n=24/147) had low HDL-C levels, 53.8% (n=78/145) had high LDL-C levels and 14.9% (n=22/148) had raised TG levels. Nearly half of the patients (48.7%; n=75/154; 95% CI 41.6 - 55.1) were hypertensive and 93.5% (n=144/154) were poorly controlled (HbA1c >7.5%). Dyslipidaemia was not associated with HT or BMI percentile and its prevalence did not change between the two specified periods. Prevalence of dyslipidaemia and HT was not associated with duration of diabetes. About one-third (30.8% (n=4/13); 95% CI 11.9 - 59.3) of the pre-adolescents and 60.3% (n=85/141; 95% CI 51.9 - 68.1) of the adolescents had dyslipidaemia (p=0.04). Dyslipidaemia was diagnosed in 62.6% (n=82/131) of adolescents with poorly controlled diabetes (p=0.04) and in 71.7% (95% CI 59.0 - 81.7) of patients ≥16 years of age (p=0.005).
Conclusions. Poor glycaemic control, dyslipidaemia and HT are common in diabetic children, putting them at risk of cardiovascular complications in adulthood.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The SAJCH is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 2010;39(3):481-497 https://doi. org/10.1016/j.ecl.2010.05.011
Robertson A. Chronic conditions in children. S Afr Health Rev 2006;15(1):257-270.
Pulgaron ER, Delamater AM. Obesity and type 2 diabetes in children: epidemiology and treatment. Curr Diab Rep 2014;14(8):508. https://doi. org/10.1007%2Fs11892-014-0508-y
Jenkins AJ, Lyons TJ, Zheng D, et al. Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Cohort. Diab Care 2003;26(3):810-818. https://doi.org/10.2337/ diacare.26.3.810
Schwab KO, Doerfer J, Hecker W, et al. Spectrum and prevalence of atherogenic risk factors in 27 358 children, adolescents, and young adults with type 1 diabetes. Diab Care 2006;29(2):218-225. https://doi.org/10.2337/ diacare.29.02.06.dc05-0724
Laing SP, Swerdlow AJ, Carpenter M, et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke 2003;34(2):418-421. https://doi.org/10.1161/01.STR.0000053843.03997.35
Harrington J, Peña AS, Gent R, et al. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr 2010;156(2):237-241. https://doi.org/10.1016/j.jpeds.2009.08.036
Järvisalo MJ, Putto-Laurila A, Jartti L, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes 2002;51(2):493-498. https:// doi.org/10.2337/diabetes.51.2.493
Järvisalo MJ. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004;109(14):1750-1755.
McGill HC Jr, McMahan CA, Henerick EE, et al. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 2000;72(Suppl):1307S-1315S. https://doi.org.ez.sun.ac.za/10.1093/ajcn/72.5.1307s
Blom DJ. Elevated triglycerides: A matter of the heart and pancreas. S Afr Med J 2018;108(4):258-261. https://doi.org/10.7196/SAMJ.2018.v108i4.13235
Donaghue KC, Marovecchio ML, Wadwa RP, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 2018;19(Suppl 27):262-274. https:// doi.org/10.1111./pedi.12742
Kajee Z, Harvey J, Zöllner EW. The impact of a diabetes care team on the glycaemic control of paediatric and adolescent patients with type 1 diabetes mellitus at Tygerberg Children’s Hospital. S Afr J Child Health 2019;13(1):11-16. https://doi.org/10.7196/SAJCH.2019.v13i1.1492
Lurbe E, Agabiti-Rosei E, Cruikshank JK, et al. European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertension 2016;34(10):1887-1920. https://doi.org/10.1097/ HJH.0000000000001039
DonaghueKC,WadwaRP,DimeglioLA,etal.ISPADClinicalPracticeConsensus Guidelines 2014 Compedium. Microvascular and macrovascular complications in children and adolescents. Pediatr Diabetes 2014;15(Suppl 20):257-269. https:// doi.org/10.1111./pedi.12180
US Preventive Services Task Force. Screening for Obesity in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. Pediatrics 2010;125(2):361-367. https://doi.org/10.1542/peds.2009-2037
World Health Organization. Adolescence: A period needing special attention. Recognizing adolescence. https://apps.who.int/adolescent/second-decade/ section2/page1/recognizing-adolescence.html (accessed 10 June 2021).
Edge JA, James T, Shine B. Longitudinal screening of serum lipids in children and adolescents with type 1 diabetes in a UK clinic population. Diabet Med 2008;25(8):942-948. https://doi.org/10.1111/j.1464-5491.2008.02518.x
Kershnar AK, Daniels SR, Imperatore G, et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The Search for Diabetes in Youth study. J Pediatr 2006;149:314-319. https://doi.org/10.1016/j.jpeds.2006.04.065
Weihrauch-Blüher S, Wiegand S. Risk factors and implications of childhood obesity. Curr Obes Rep 2018;7:254-259. https://doi.org/10.1007/s13679-018- 0320-0
Boyer BP, Nelson JA, Holub SC. Childhood body mass index trajectories predicting cardiovascular risk in adolescence. J Adolesc Health 2015;56(6):599- 605. https://doi.org/10.1016/j.jadohealth.2015.01.006
Saeedi R, Frohlich J. Lipoprotein (a), an independent cardiovascular risk marker. Clin Diab Endocrinol 2016;2(7):1-6. https://doi.org/10. 1186/s40842-016-0024-x